ES2170733B1 - Metodo para preparar citalopram purificado - Google Patents

Metodo para preparar citalopram purificado

Info

Publication number
ES2170733B1
ES2170733B1 ES200101763A ES200101763A ES2170733B1 ES 2170733 B1 ES2170733 B1 ES 2170733B1 ES 200101763 A ES200101763 A ES 200101763A ES 200101763 A ES200101763 A ES 200101763A ES 2170733 B1 ES2170733 B1 ES 2170733B1
Authority
ES
Spain
Prior art keywords
citalopram
preparing purified
base
product
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn - After Issue
Application number
ES200101763A
Other languages
English (en)
Other versions
ES2170733A1 (es
Inventor
Andrea Castellin
Giulio Volpe
Federico Sbrogio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of ES2170733A1 publication Critical patent/ES2170733A1/es
Application granted granted Critical
Publication of ES2170733B1 publication Critical patent/ES2170733B1/es
Anticipated expiration legal-status Critical
Withdrawn - After Issue legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Método para preparar citalopram purificado, caracterizado porque el producto de citalopram crudo se somete opcionalmente a una purificación adicional; y la base de citalopram cruda se somete subsiguientemente a un proceso de destilación en película para separar impurezas de la reacción de elevado peso molecular; después, el producto de citalopram resultante se purifica opcionalmente de forma adicional y se elabora y aísla en forma de la base o una sal farmacéuticamente aceptable del mismo.
ES200101763A 2000-12-28 2001-07-27 Metodo para preparar citalopram purificado Withdrawn - After Issue ES2170733B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200001943 2000-12-28

Publications (2)

Publication Number Publication Date
ES2170733A1 ES2170733A1 (es) 2002-08-01
ES2170733B1 true ES2170733B1 (es) 2003-12-16

Family

ID=8159933

Family Applications (2)

Application Number Title Priority Date Filing Date
ES01913727T Expired - Lifetime ES2181663T3 (es) 2000-12-28 2001-03-07 Procedimiento para la preparacion de citalopram puro.
ES200101763A Withdrawn - After Issue ES2170733B1 (es) 2000-12-28 2001-07-27 Metodo para preparar citalopram purificado

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES01913727T Expired - Lifetime ES2181663T3 (es) 2000-12-28 2001-03-07 Procedimiento para la preparacion de citalopram puro.

Country Status (41)

Country Link
US (2) US6855834B2 (es)
EP (1) EP1181272B1 (es)
JP (1) JP2003519121A (es)
KR (1) KR100430746B1 (es)
CN (1) CN1366526A (es)
AR (1) AR029898A1 (es)
AT (2) ATE222899T1 (es)
AU (3) AU3920201A (es)
BE (2) BE1013417A6 (es)
BG (1) BG106219A (es)
BR (1) BR0106271A (es)
CA (1) CA2359810C (es)
CH (1) CH691536A5 (es)
CZ (1) CZ293140B6 (es)
DE (1) DE60100016T2 (es)
DK (1) DK1181272T3 (es)
EA (1) EA003459B1 (es)
ES (2) ES2181663T3 (es)
FI (2) FI108640B (es)
FR (1) FR2818977B1 (es)
GB (2) GB2356199B (es)
GR (1) GR20010100131A (es)
HK (1) HK1049332A1 (es)
HR (1) HRP20020005A2 (es)
HU (2) HU0101028D0 (es)
IE (2) IES20010253A2 (es)
IL (1) IL147162A0 (es)
IS (1) IS5884A (es)
IT (1) ITMI20010604A1 (es)
MX (1) MXPA01013336A (es)
NL (1) NL1017534C1 (es)
NO (1) NO313047B1 (es)
NZ (1) NZ516299A (es)
PL (1) PL353369A1 (es)
PT (1) PT1181272E (es)
SE (1) SE0103044L (es)
SK (1) SK284418B6 (es)
TR (1) TR200200018T1 (es)
UA (1) UA71635C2 (es)
WO (1) WO2001047877A2 (es)
ZA (1) ZA200110133B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
HU227473B1 (en) 1999-04-14 2011-07-28 Lundbeck & Co As H Method for preparation of citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
SK287139B6 (sk) 1999-10-25 2010-01-07 H. Lundbeck A/S Spôsob prípravy citalopramu
ATE277032T1 (de) 1999-10-25 2004-10-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
AU778751B2 (en) 1999-12-28 2004-12-16 H. Lundbeck A/S Method for the preparation of citalopram
EP1246813B1 (en) 1999-12-30 2003-11-05 H. Lundbeck A/S Method for the preparation of citalopram
EA005134B1 (ru) 2000-01-14 2004-12-30 Х.Лундбекк А/С Способ получения 5-цианофталида
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
TR200202195T2 (tr) 2000-03-13 2002-12-23 H. Lundbeck A/S 5-Yer değiştirmiş 1-(4-florofenil)-1,3- dihidroizobenzofuran'ın adım adım alkillenmesi
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
EA200200969A1 (ru) 2000-03-13 2003-02-27 Х.Лундбекк А/С Способ получения циталопрама
ES2214400T3 (es) 2000-03-14 2004-09-16 H. Lundbeck A/S Metodo para la preparacion de citalopram.
JP2003527388A (ja) * 2000-03-16 2003-09-16 ハー・ルンドベック・アクチエゼルスカベット 5−シアノ−1−(4−フルオロフェニル)−1,3−ジヒドロイソベンゾフランの製造方法
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
CA2354877C (en) 2000-08-18 2006-05-02 H. Lundbeck A/S Method for the preparation of citalopram
SI1181713T1 (en) 2000-12-22 2005-02-28 H. Lundbeck A/S Method for the preparation of pure citalopram
CA2359810C (en) 2000-12-28 2002-11-05 H. Lundbeck A/S Process for the preparation of pure citalopram
GB2376945A (en) * 2001-06-27 2002-12-31 Cipla Ltd Citalopram preparation
AU2003222435A1 (en) 2002-01-07 2003-07-24 Sun Pharmaceutical Industries Limited Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
ES2194597B2 (es) * 2002-01-25 2004-08-01 Esteve Quimica, S.A. Procedimiento para la obtencion de citalopram.
GB0204607D0 (en) 2002-02-27 2002-04-10 Matrix Lab Ltd Process
GB2386119A (en) * 2002-02-27 2003-09-10 Cipla Ltd Purification of citalopram
EP1346989A1 (en) * 2002-03-21 2003-09-24 Jubilant Organosys Limited Improved process for the preparation of citalopram and its hydrobromide
WO2004085416A1 (en) * 2003-03-24 2004-10-07 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
US7019153B2 (en) 2003-06-10 2006-03-28 Sun Pharmaceutical Industries Limited Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
CN100569765C (zh) 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL135959C (es) 1964-12-23
GB1143702A (es) 1965-03-18
DE1619713A1 (de) * 1967-03-29 1970-12-17 Leybold Heraeus Gmbh & Co Kg Vorrichtung zur Vakuum- und Kurzwegdestillation
DE2135085C3 (de) 1971-07-14 1981-12-03 Basf Ag, 6700 Ludwigshafen Verfahren zur Wiedergewinnung von Caprolactam aus einem Gemisch, das Caprolactam und dessen Oligomere enthält
DE2442426C2 (de) 1974-09-05 1983-04-07 Bayer Ag, 5090 Leverkusen Diisocyanatodiketene, Verfahren zu deren Herstellung und deren Verwendung
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
IT8020902A0 (it) 1980-03-25 1980-03-25 Snia Viscosa Procedimento ed apparecchiatura per la separazione continua per via termica di miscele liquide dicomposti termolabili.
JPS6082101A (ja) 1983-10-13 1985-05-10 Mitsui Toatsu Chem Inc 高沸点重合性化合物の薄膜蒸留による精製方法
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
FR2656305B1 (fr) 1989-12-22 1992-04-10 Norsolor Sa Procede de purification du (meth)acrylate de glycidyle.
US5296507A (en) 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
US5582692A (en) 1994-10-07 1996-12-10 Artisan Industries, Inc. Method for the purification of vitamin E
EP0901481B1 (en) 1996-05-21 2003-10-22 ExxonMobil Chemical Patents Inc. Purification of glycidyl esters by thin film evaporation
US6136991A (en) * 1996-05-21 2000-10-24 Exxon Chemical Patents Inc. Glycidyl ester adducts having increased glass transition temperatures
DE19626659A1 (de) 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
JP3526581B2 (ja) 1997-07-08 2004-05-17 ハー・ルンドベック・アクティーゼルスカブ シタロプラムの製造方法
DE19734673A1 (de) 1997-08-11 1999-02-18 Rwe Dea Ag Verfahren zur Herstellung von metallfreien Guerbetalkoholen
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
CA2291072C (en) 1997-11-11 2002-08-20 H. Lundbeck A/S Method for the preparation of citalopram
EP0965593B2 (en) 1998-06-19 2008-12-03 Shin-Etsu Chemical Co., Ltd. Distillation of (meth)acryloxybearing alkoxysilane
DK1123284T3 (da) * 1998-10-20 2003-04-28 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
SI1140886T1 (en) 1998-12-23 2003-08-31 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
HU227473B1 (en) 1999-04-14 2011-07-28 Lundbeck & Co As H Method for preparation of citalopram
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
SK287139B6 (sk) 1999-10-25 2010-01-07 H. Lundbeck A/S Spôsob prípravy citalopramu
US6310222B1 (en) 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
SI1181713T1 (en) 2000-12-22 2005-02-28 H. Lundbeck A/S Method for the preparation of pure citalopram
CA2359810C (en) 2000-12-28 2002-11-05 H. Lundbeck A/S Process for the preparation of pure citalopram
US6781003B1 (en) * 2003-06-09 2004-08-24 Aurobindo Pharma Ltd. Preparation of pure citalopram

Also Published As

Publication number Publication date
IES20010632A2 (en) 2002-03-06
HK1049332A1 (zh) 2003-05-09
CZ2001891A3 (cs) 2002-08-14
EA200200016A1 (ru) 2002-04-25
CZ293140B6 (cs) 2004-02-18
HUP0102818A2 (hu) 2001-12-28
NL1017534C1 (nl) 2001-04-26
US20020087012A1 (en) 2002-07-04
AU2001100399A4 (en) 2001-11-01
SE0103044D0 (sv) 2001-09-14
CA2359810A1 (en) 2001-07-05
AT4368U1 (de) 2001-06-25
ZA200110133B (en) 2003-01-13
FI108640B (fi) 2002-02-28
SK284418B6 (sk) 2005-04-01
AU2001100399B4 (en) 2002-03-21
CA2359810C (en) 2002-11-05
FI20011578A0 (fi) 2001-07-26
NO20011272D0 (no) 2001-03-13
HRP20020005A2 (en) 2003-04-30
EA003459B1 (ru) 2003-06-26
US20030178295A1 (en) 2003-09-25
GR20010100131A (el) 2002-10-09
FI20010501A0 (fi) 2001-03-13
GB2356199A (en) 2001-05-16
FR2818977B1 (fr) 2003-12-05
NO313047B1 (no) 2002-08-05
KR100430746B1 (ko) 2004-05-10
SK18472001A3 (sk) 2002-05-09
FR2818977A1 (fr) 2002-07-05
HU0101028D0 (en) 2001-05-28
NZ516299A (en) 2002-12-20
ITMI20010604A0 (it) 2001-03-22
HUP0102818A3 (en) 2003-07-28
GB2361697A (en) 2001-10-31
MXPA01013336A (es) 2002-07-09
CN1366526A (zh) 2002-08-28
KR20020073379A (ko) 2002-09-26
PT1181272E (pt) 2003-01-31
WO2001047877A2 (en) 2001-07-05
ATE222899T1 (de) 2002-09-15
ES2170733A1 (es) 2002-08-01
IES20010253A2 (en) 2002-03-06
TR200200018T1 (tr) 2002-06-21
DE60100016D1 (de) 2002-10-02
GB0117095D0 (en) 2001-09-05
HU0102818D0 (en) 2001-09-28
SE0103044L (sv) 2002-06-29
IL147162A0 (en) 2002-08-14
CH691536A5 (de) 2001-08-15
GB0105981D0 (en) 2001-05-02
BE1013316A6 (fr) 2001-11-06
AU750006B1 (en) 2002-07-11
ITMI20010604A1 (it) 2002-09-22
DE60100016T2 (de) 2003-04-17
PL353369A1 (en) 2003-11-17
NO20011272L (no) 2002-07-01
EP1181272B1 (en) 2002-08-28
WO2001047877A3 (en) 2001-12-27
AR029898A1 (es) 2003-07-23
BR0106271A (pt) 2002-05-21
JP2003519121A (ja) 2003-06-17
BG106219A (en) 2002-08-30
US6855834B2 (en) 2005-02-15
EP1181272A2 (en) 2002-02-27
AU3920201A (en) 2001-07-09
IS5884A (is) 2002-06-28
UA71635C2 (uk) 2004-12-15
GB2356199B (en) 2001-10-03
BE1013417A6 (fr) 2001-12-04
ES2181663T3 (es) 2003-03-01
DK1181272T3 (da) 2002-12-30

Similar Documents

Publication Publication Date Title
ES2170733B1 (es) Metodo para preparar citalopram purificado
AR042320A1 (es) Procedimiento para la purificacion oxidativa de acido tereftalico
BRPI0410685A (pt) processos de purificação de 1,3-propanodiol e composições
MY164459A (en) Conversion of a multihydroxylated-aliphatic hydrocarbon or ester thereof to a chlorohydrin
WO2007089851A3 (en) Compositions and methods for treating collagen-mediated diseases
AR030056A1 (es) Proceso para la preparacion de citalopram purificado
AU5377100A (en) Process for extraction and purification of paclitaxel from natural sources
NO20065942L (no) Gjenvinning av 2,6-naftalendiakarboksylsyre (2,6-NDA) inneholdt i polyetylennaftalat i en fremgangsmate for a fremstille diestere
HUP9900110A2 (hu) Új eljárás omeprazol szintézisére
EP1361203A3 (en) Process for manufacturing high purity methacrylic acid
ATE338016T1 (de) Verfahren zur reinigung von hexafluor-1,3- butadien
DE60117860D1 (de) Kristallisierungsverfahren zur herstellung von sehr reinem para-xylol
TW200616947A (en) Process
EP1578763A4 (en) PURIFICATION PROCESS FOR PLASMID DNA
MX2023004496A (es) Procesos para purificar acido acetico e hidratar un anhidrido.
ATE402157T1 (de) Verfahren zur herstellung von mycophenolatmofetil
AR001785A1 (es) Composición farmacéutica para la inhibición de producción o secreción de tnf - alfa
TNSN06066A1 (en) Process for the purification of terbinafine
DE60031133D1 (de) Verfahren zur darstellung von lh-rh-derivaten
RU94038599A (ru) Способ очистки хлороформа
JP2000104128A5 (es)
ATE306558T1 (de) Herstellung und reinigung von cyclosporin-a
ATE478839T1 (de) Verfahren zur herstellung von kristallinem dexloxiglumid
BR0308062A (pt) Método para purificar uma base de citalopram, base de citalopram, sal de citalopram farmaceuticamente aceitável, método para fabricar o mesmo, e, composição farmacêutica
JPH08109154A (ja) 蟻酸ビニルの蒸留による精製法

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20020801

Kind code of ref document: A1

Effective date: 20020801

FG2A Definitive protection

Ref document number: 2170733B1

Country of ref document: ES

FA2A Application withdrawn

Effective date: 20050301